FDA Inspection 992915 — Guangxi Yulin Pharmaceutical Group Co. Ltd.
The FDA completed an inspection of Guangxi Yulin Pharmaceutical Group Co. Ltd. on Sep 29, 2016 in Yulin. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 29, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Yulin (China)